Is a titer of 1:32 positive considered cured?
Nov 29, 2025
Source: Cainiu Health
Dr. Zhang Lu
Introduction
If standard treatment has been completed and the titer has decreased from a higher level to a positive 1:32, the patient may be in the recovery phase but has not yet achieved full cure. In some patients, titers gradually decline after treatment, requiring continuous monitoring for 3–6 months. If the titer continues to decrease or remains stable, the patient may enter the clinically cured stage; however, if the titer shows no change or increases, the treatment plan should be re-evaluated and interventions adjusted accordingly.
Generally, a titer of 1:32 positive is not considered cured and often indicates that the infection is still present or the individual is in the recovery phase. Further evaluation should be based on the specific medical history. If in doubt, it is recommended to seek medical advice promptly. Detailed analysis is as follows:
If no standardized treatment has been previously received, a positive titer of 1:32 suggests that the infection remains active and does not meet the criteria for cure. At this stage, the pathogen has not been effectively eliminated from the body and may still be transmissible. Standardized treatment should be initiated promptly. Regular follow-up testing of the titer is necessary after treatment to monitor trends in the values and assess therapeutic effectiveness.
If standardized treatment has already been completed and the titer has decreased from a higher level to 1:32 positive, the individual may be in the recovery phase but is still not considered cured. In some patients, the titer gradually declines after treatment. Continuous monitoring for 3–6 months is required. If the titer continues to decrease or remains stable, the patient may enter the clinically cured stage. However, if the titer remains unchanged or increases, the treatment plan should be re-evaluated and interventions adjusted accordingly.
After detecting a positive titer of 1:32, it is important to provide the doctor with a complete medical history, including details of prior treatments and follow-up test records. Follow the doctor’s instructions strictly for subsequent examinations and treatment; do not discontinue medication or adjust the treatment plan independently. Regular titer monitoring is essential, and any abnormal changes should be promptly discussed with the physician.
